Report Update Nov 1, 2024

Pakistan - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Pakistan: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Pakistan

The Pakistani medicaments containing insulin market reached $X in 2021, rising by 2.4% against the previous year. Over the period under review, consumption recorded buoyant growth. Over the period under review, the market hit record highs at $X in 2019; afterwards, it flattened through to 2021.

Medicaments Containing Insulin Production in Pakistan

In value terms, medicaments containing insulin production rose slightly to $X in 2021 estimated in export price. Overall, the total production indicated a tangible expansion from 2012 to 2021: its value increased at an average annual rate of +4.5% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, production decreased by -2.6% against 2019 indices. The pace of growth appeared the most rapid in 2019 when the production volume increased by 22%. As a result, production reached the peak level of $X; afterwards, it flattened through to 2021.

Medicaments Containing Insulin Exports

Exports from Pakistan

In 2021, shipments abroad of medicaments containing insulin but not antibiotics increased by 48% to X kg, rising for the second consecutive year after three years of decline. Over the period under review, exports, however, continue to indicate a sharp descent. The most prominent rate of growth was recorded in 2013 with an increase of 173% against the previous year. Over the period under review, the exports hit record highs at X tons in 2016; however, from 2017 to 2021, the exports failed to regain momentum.

In value terms, medicaments containing insulin exports surged to $X in 2021. In general, exports, however, faced a sharp descent. The pace of growth appeared the most rapid in 2013 when exports increased by 143%. The exports peaked at $X in 2016; however, from 2017 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

Guyana (X kg) was the main destination for medicaments containing insulin exports from Pakistan, with a approx. 100% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of volume to Guyana stood at +34.4%.

In value terms, Guyana ($X) also remains the key foreign market for medicaments containing insulin but not antibiotics exports from Pakistan.

From 2012 to 2021, the average annual rate of growth in terms of value to Guyana amounted to +5.6%.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, waning by -5.4% against the previous year. Overall, export price indicated a perceptible increase from 2012 to 2021: its price increased at an average annual rate of +2.6% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, medicaments containing insulin export price decreased by -16.6% against 2019 indices. The pace of growth was the most pronounced in 2017 an increase of 25%. The export price peaked at $X per ton in 2019; however, from 2020 to 2021, the export prices stood at a somewhat lower figure.

As there is only one major export destination, the average price level is determined by prices for Guyana.

From 2012 to 2021, the rate of growth in terms of prices for Guyana amounted to -21.8% per year.

Medicaments Containing Insulin Imports

Imports into Pakistan

In 2021, the amount of medicaments containing insulin but not antibiotics imported into Pakistan amounted to X tons, picking up by 2.6% compared with the year before. Over the period under review, imports, however, showed a relatively flat trend pattern. The growth pace was the most rapid in 2016 with an increase of 106%. Imports peaked at X tons in 2012; however, from 2013 to 2021, imports failed to regain momentum.

In value terms, medicaments containing insulin imports expanded notably to $X in 2021. In general, imports recorded a strong expansion. The pace of growth appeared the most rapid in 2016 when imports increased by 164% against the previous year. Imports peaked in 2021 and are expected to retain growth in years to come.

Imports by Country

In 2021, India (X tons) was the main supplier of medicaments containing insulin to Pakistan, accounting for a approx. 100% share of total imports.

From 2012 to 2021, the average annual growth rate of volume from India was relatively modest.

In value terms, India ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Pakistan.

From 2012 to 2021, the average annual rate of growth in terms of value from India amounted to +17.4%.

Import Prices by Country

In 2021, the average medicaments containing insulin import price amounted to $X per ton, picking up by 3.6% against the previous year. Over the period under review, the import price showed a remarkable increase. The pace of growth was the most pronounced in 2014 an increase of 63%. Over the period under review, average import prices attained the peak figure at $X per ton in 2017; however, from 2018 to 2021, import prices stood at a somewhat lower figure.

As there is only one major supplying country, the average price level is determined by prices for India.

From 2012 to 2021, the rate of growth in terms of prices for India amounted to +17.9% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the world?

The country with the largest volume of medicaments containing insulin consumption was Denmark, accounting for 58% of total volume. Moreover, medicaments containing insulin consumption in Denmark exceeded the figures recorded by the second-largest consumer, the U.S., sevenfold. The third position in this ranking was occupied by Pakistan, with a 3.6% share.

What are the largest producers of medicaments containing insulin but not antibiotics in the world?

The country with the largest volume of medicaments containing insulin production was the U.S., comprising approx. 80% of total volume. Moreover, medicaments containing insulin production in the U.S. exceeded the figures recorded by the second-largest producer, Denmark, more than tenfold. The third position in this ranking was occupied by Pakistan, with a 2.5% share.

What are the leading suppliers of medicaments containing insulin but not antibiotics to Pakistan?

In value terms, Denmark constituted the largest supplier of medicaments containing insulin to Pakistan.

What are the leading importers of medicaments containing insulin but not antibiotics from Pakistan?

In value terms, Guyana remains the key foreign market for medicaments containing insulin exports from Pakistan.

What is the average export price for medicaments containing insulin but not antibiotics in Pakistan?

The average medicaments containing insulin export price stood at $96,000 per ton in 2020, surging by 24% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in Pakistan?

In 2018, the average medicaments containing insulin import price amounted to $64,049 per ton, picking up by 25% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Pakistan. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Pakistan

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in Pakistan
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption In 2012-2023
5. Imports, In Physical Terms, By Country, 2012–2023
6. Imports, In Value Terms, By Country, 2012–2023
7. Import Prices, By Country Of Origin, 2012–2023
8. Exports, In Physical Terms, By Country, 2012–2023
9. Exports, In Value Terms, By Country, 2012–2023
10. Export Prices, By Country Of Destination, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
5. Trade Balance, In Physical Terms, 2012-2023
6. Trade Balance, In Value Terms, 2012-2023
7. Per Capita Consumption, 2012-2023
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2023
22. Production, In Value Terms, 2012–2023
23. Imports, In Physical Terms, 2012–2023
24. Imports, In Value Terms, 2012–2023
25. Imports, In Physical Terms, By Country, 2023
26. Imports, In Physical Terms, By Country, 2012–2023
27. Imports, In Value Terms, By Country, 2012–2023
28. Import Prices, By Country Of Origin, 2012–2023
29. Exports, In Physical Terms, 2012–2023
30. Exports, In Value Terms, 2012–2023
31. Exports, In Physical Terms, By Country, 2023
32. Exports, In Physical Terms, By Country, 2012–2023
33. Exports, In Value Terms, By Country, 2012–2023
34. Export Prices, By Country Of Destination, 2012–2023